World's Best Scientists 2026 revealed!
Silvia C. Formenti

Silvia C. Formenti

D-Index & Metrics

Medicine

D-Index
94
Citations
48014
World Ranking
10267
National Ranking
5277

Research.com Recognitions

  • Member of the Association of American Physicians
  • Member of the Association of American Physicians

Overview

Silvia C. Formenti is affiliated with Cornell University in the United States and has a primary research focus within the field of Medicine, particularly in Oncology, Immunology, and Pulmonary and Respiratory Medicine. Their body of work includes 208 publications in Medicine, with a strong emphasis on subfields such as Oncology (100 publications), Immunology (46 publications), Pulmonary and Respiratory Medicine (43 publications), Cancer Research (18 publications), and Radiology, Nuclear Medicine and Imaging (17 publications).

The main topics of Formenti's research include:

  • Cancer Immunotherapy and Biomarkers
  • Immunotherapy and Immune Responses
  • CAR-T cell therapy research
  • Breast Cancer Treatment Studies
  • Advanced Radiotherapy Techniques
  • Immune Cell Function and Interaction
  • Lung Cancer Treatments and Mutations

Frequent venues where their work has been published are:

  • International Journal of Radiation Oncology*Biology*Physics (17 publications)
  • Clinical Cancer Research (8 publications)
  • Nature Communications (6 publications)
  • Cancer Research (6 publications)
  • Cancer Immunology Research (5 publications)

Key recent papers authored or coauthored by Formenti include:

  • "Consensus guidelines for the definition, detection and interpretation of immunogenic cell death," 2020, Journal for ImmunoTherapy of Cancer
  • "Mitochondrial DNA drives abscopal responses to radiation that are inhibited by autophagy," 2020, Nature Immunology
  • "Neoadjuvant durvalumab with or without stereotactic body radiotherapy in patients with early-stage non-small-cell lung cancer: a single-centre, randomised phase 2 trial," 2021, The Lancet Oncology
  • "Emerging evidence for adapting radiotherapy to immunotherapy," 2023, Nature Reviews Clinical Oncology
  • "Radiation dose and fraction in immunotherapy: one-size regimen does not fit all settings, so how does one choose?" 2021, Journal for ImmunoTherapy of Cancer

Throughout their career, Formenti has collaborated extensively with other researchers, including frequent coauthors such as Lorenzo Galluzzi, Sandra Demaria, Giulia Petroni, Norma Bloy, and Xi Kathy Zhou.

The scientist has been recognized as a Member of the Association of American Physicians.

Best Publications

  • Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota

    Marie Vétizou;Marie Vétizou;Marie Vétizou;Jonathan M. Pitt;Jonathan M. Pitt;Jonathan M. Pitt;Romain Daillère;Romain Daillère;Romain Daillère;Patricia Lepage

  • Fractionated but not single dose radiotherapy induces an immune-mediated abscopal effect when combined with anti-CTLA-4 antibody

    M. Zahidunnabi Dewan;Ashley E. Galloway;Noriko Kawashima;J. Keith Dewyngaert

  • DNA exonuclease Trex1 regulates radiotherapy-induced tumour immunogenicity.

    Claire Vanpouille-Box;Amandine Alard;Amandine Alard;Molykutty J. Aryankalayil;Yasmeen Sarfraz

  • Ionizing radiation inhibition of distant untreated tumors (abscopal effect) is immune mediated

    Sandra Demaria;Bruce Ng;Mary Louise Devitt;James S Babb

  • Using immunotherapy to boost the abscopal effect

    Wilfred Ngwa;Omoruyi Credit Irabor;Jonathan D. Schoenfeld;Jürgen Hesser

  • Postmastectomy Radiotherapy: Clinical Practice Guidelines of the American Society of Clinical Oncology*

    Abram Recht;Stephen B. Edge;Lawrence J. Solin;David S. Robinson

  • Immune-mediated inhibition of metastases after treatment with local radiation and CTLA-4 blockade in a mouse model of breast cancer.

    Sandra Demaria;Noriko Kawashima;Anne Marie Yang;Mary Louise Devitt

  • Systemic effects of local radiotherapy

    Silvia C Formenti;Sandra Demaria

  • Combining Radiotherapy and Cancer Immunotherapy: A Paradigm Shift

    Silvia C. Formenti;Sandra Demaria

  • Translational control in cancer.

    Deborah Silvera;Silvia C. Formenti;Robert J. Schneider

  • Consensus guidelines for the definition, detection and interpretation of immunogenic cell death

    Lorenzo Galluzzi;Ilio Vitale;Sarah Warren;Sandy Adjemian

  • Previous radiotherapy and the clinical activity and toxicity of pembrolizumab in the treatment of non-small-cell lung cancer: a secondary analysis of the KEYNOTE-001 phase 1 trial

    Narek Shaverdian;Aaron E Lisberg;Krikor Bornazyan;Darlene Veruttipong

  • Radiotherapy induces responses of lung cancer to CTLA-4 blockade

    Silvia C. Formenti;Nils Petter Rudqvist;Encouse Golden;Encouse Golden;Benjamin Cooper

  • Enterococcus hirae and Barnesiella intestinihominis Facilitate Cyclophosphamide-Induced Therapeutic Immunomodulatory Effects

    Romain Daillère;Romain Daillère;Romain Daillère;Marie Vétizou;Marie Vétizou;Marie Vétizou;Nadine Waldschmitt;Takahiro Yamazaki;Takahiro Yamazaki

  • Consensus guidelines for the detection of immunogenic cell death

    Oliver Kepp;Laura Senovilla;Ilio Vitale;Erika Vacchelli

  • Radiation-induced CXCL16 release by breast cancer cells attracts effector T cells.

    Satoko Matsumura;Baomei Wang;Noriko Kawashima;Steve Braunstein

  • Role of Local Radiation Therapy in Cancer Immunotherapy

    Sandra Demaria;Encouse B. Golden;Silvia C. Formenti

  • An Abscopal Response to Radiation and Ipilimumab in a Patient with Metastatic Non-Small Cell Lung Cancer

    Encouse B. Golden;Sandra Demaria;Peter B. Schiff;Abraham Chachoua

  • Local radiotherapy and granulocyte-macrophage colony-stimulating factor to generate abscopal responses in patients with metastatic solid tumours: a proof-of-principle trial.

    Encouse B Golden;Arpit Chhabra;Abraham Chachoua;Sylvia Adams

  • Radiation fosters dose-dependent and chemotherapy-induced immunogenic cell death.

    Encouse B Golden;Derek Frances;Ilenia Pellicciotta;Sandra Demaria

Frequent Co-Authors

Sandra Demaria
Sandra Demaria Cornell University
Robert J. Schneider
Robert J. Schneider New York University
Lorenzo Galluzzi
Lorenzo Galluzzi Cornell University
Franco M. Muggia
Franco M. Muggia New York University
Sylvia Adams
Sylvia Adams New York University
Paul J. Christos
Paul J. Christos Cornell University
William H. McBride
William H. McBride University of California, Los Angeles
Takahiro Yamazaki
Takahiro Yamazaki Cornell University
Guido Kroemer
Guido Kroemer Université Paris Cité
Laurence Zitvogel
Laurence Zitvogel University of Paris-Saclay

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Medicine is a rewarding field, but there are many alternative and complementary career paths in healthcare. For those interested in patient care but seeking a different route, nursing remains a popular choice. The question often arises: do you have to take the teas test to get into nursing school? Many nursing programs now offer flexible admissions, which can make entry easier for a wider range of applicants.

For those drawn to the business side of healthcare, an online degree in administration provides a fast track to leadership roles. Check out the options for a healthcare administration online degree to jumpstart your management career within hospitals and clinics.

Nurses looking to advance further may consider specialized bridge programs, such as rn to fnp bridge programs, which allow registered nurses to become family nurse practitioners through flexible online study.

Finally, for those interested in diet and wellness, earning nutrition degrees online can open doors to careers in counseling, research, and health advocacy. These programs offer a science-based foundation for supporting public health and personal well-being.

Best Scientists Citing Silvia C. Formenti

Trending Scientists